Anti-PD1 antibodies in patients aged ≥ 75 years with metastatic melanoma: A retrospective multicentre study.

Journal of Geriatric Oncology(2020)

引用 31|浏览86
暂无评分
摘要
Anti-PD1 antibodies appear effective and well tolerated in older patients with advanced melanoma.
更多
查看译文
关键词
Melanoma,Immunotherapy,Older patients,Aging,Immunosenescence,Drug effects
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要